23andMe Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:23andMe Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010853
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization services, and information of personal ancestry, genealogy and inherited traits. 23andMe’s ancestry services comprise ancestry composition, family tree tool, DNA relatives, maternal and paternal lineages, and neanderthal percentage. The company helps individuals to understand their genetic information using DNA analysis technologies and web-based interactive tools. It caters to students, clinicians, and developers. 23andMe is headquartered in Mountain View, California, the US.

23andMe Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
23andMe Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
23andMe Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
23andMe Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
23andMe Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
23andMe Inc, Medical Devices Deals, 2011 to YTD 2017 9
23andMe Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
23andMe Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
23andMe Raises USD250 Million in Venture Financing 11
23andMe Raises USD79.07 Million in Venture Financing 13
23andMe Raises Additional USD9 Million in Series C Financing 14
Partnerships 15
H. Lundbeck Enters into Agreement with 23andMe and Milken Institute 15
Reset Therapeutics Enters into Research Agreement with 23andMe 16
23andMe Partners with Genentech 17
23andMe Inc – Key Competitors 18
23andMe Inc – Key Employees 19
23andMe Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Feb 22, 2017: Celmatix and 23andMe Announce Launch of Fertility Research Community 21
Apr 05, 2016: New Effort by 23andMe Could Increase Diversity in Genetic Research 22
Product News 23
Aug 02, 2017: 23andMe Enrolling For First-of-its-Kind Study on Major Depressive and Bipolar Disorders 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
23andMe Inc, Pharmaceuticals & Healthcare, Key Facts 2
23andMe Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
23andMe Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
23andMe Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
23andMe Inc, Deals By Therapy Area, 2011 to YTD 2017 8
23andMe Inc, Medical Devices Deals, 2011 to YTD 2017 9
23andMe Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
23andMe Raises USD250 Million in Venture Financing 11
23andMe Raises USD79.07 Million in Venture Financing 13
23andMe Raises Additional USD9 Million in Series C Financing 14
H. Lundbeck Enters into Agreement with 23andMe and Milken Institute 15
Reset Therapeutics Enters into Research Agreement with 23andMe 16
23andMe Partners with Genentech 17
23andMe Inc, Key Competitors 18
23andMe Inc, Key Employees 19
23andMe Inc, Subsidiaries 20

★海外企業調査レポート[23andMe Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Triangle Energy (Global) Ltd (TEG):企業の財務・戦略的SWOT分析
    Summary Triangle Energy (Global) Ltd (Triangle Energy), formerly Maverick Energy Ltd, is an oil and gas company that explores and produces oil and natural gas reserves. The company operates oil and gas assets such as Reid’s Dome and Pase Field. It holds working interest and operates the Production S …
  • Scholastic Corp (SCHL)
    Scholastic Corp (SCHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Bank of Baroda:企業の戦略・SWOT・財務情報
    Bank of Baroda - Strategy, SWOT and Corporate Finance Report Summary Bank of Baroda - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Qantas Airways Limited:企業の戦略・SWOT・財務情報
    Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Delta Air Lines Inc:戦略・SWOT・企業財務分析
    Delta Air Lines Inc - Strategy, SWOT and Corporate Finance Report Summary Delta Air Lines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • O’Reilly Automotive, Inc.:企業の戦略・SWOT・財務情報
    O'Reilly Automotive, Inc. - Strategy, SWOT and Corporate Finance Report Summary O'Reilly Automotive, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Galadari Hotels (Lanka) PLC :企業の戦略・SWOT・財務情報
    Galadari Hotels (Lanka) PLC - Strategy, SWOT and Corporate Finance Report Summary Galadari Hotels (Lanka) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company offers products such as automated nucleic acid isolation system, large sample volume nucleic acid extracti …
  • Kirby Corporation:戦略・SWOT・企業財務分析
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CEMEX, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    CEMEX, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary CEMEX, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Casual Dining Group Ltd.:企業の戦略・SWOT・財務情報
    Casual Dining Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Casual Dining Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Regal Petroleum Plc (RPT):石油・ガス:M&Aディール及び事業提携情報
    Summary Regal Petroleum Plc (Regal), a subsidiary of Energees Investments Ltd, is an oil and gas company that conducts reviews on oil and gas projects. The company operates two gas and condensate fields such as Mekhediviska - Golotovschinska and Svyrydivske located in Dneipner-Donets basin in the no …
  • Banc of California, Inc.:企業のM&A・事業提携・投資動向
    Banc of California, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banc of California, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Savanna Energy Services Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Savanna Energy Services Corp (Savanna), a subsidiary of Total Energy Services Inc, is an oilfield service provider that offers drilling, well servicing and oilfield rental services. The company conducts drilling, hybrid drilling, and well servicing and oilfield services such as oilfield equi …
  • TransMedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary TransMedics Inc (TransMedics) is a medical device company that develops organ transplant systems. The company offers organ care systems that are used by surgeons in heart transplants and ex-vivo warm perfusion and assessment of donor organs for transplantation. Its organ care systems are als …
  • NTUC Income Insurance Co-operative Limited:企業の戦略的SWOT分析
    NTUC Income Insurance Co-operative Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Jiangsu Zhongtian Technology Co Ltd (600522):企業の財務・戦略的SWOT分析
    Jiangsu Zhongtian Technology Co Ltd (600522) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Vivimed Labs Ltd (VIVIMEDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆